A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies

Clinical trial NCT00830869 · COMPLETED

Trial details

NCT number: NCT00830869
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Non-hematologic Malignancies

Start date: 2009-03-02
Primary completion: 2012-04-20
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.